DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $965,369 | -25.3% | 107,742 | -6.2% | 0.00% | – |
| Q2 2023 | $1,292,007 | -1.3% | 114,845 | +1.1% | 0.00% | – |
| Q1 2023 | $1,309,017 | +75.3% | 113,630 | +76.4% | 0.00% | – |
| Q4 2022 | $746,744 | -54.6% | 64,430 | -50.3% | 0.00% | – |
| Q3 2022 | $1,645,000 | +5.0% | 129,540 | -43.2% | 0.00% | – |
| Q2 2022 | $1,567,000 | -46.6% | 228,050 | -25.1% | 0.00% | – |
| Q1 2022 | $2,935,000 | -34.0% | 304,543 | -18.6% | 0.00% | -100.0% |
| Q4 2021 | $4,445,000 | +163.8% | 373,920 | +260.3% | 0.00% | – |
| Q3 2021 | $1,685,000 | +1619.4% | 103,778 | +2128.9% | 0.00% | – |
| Q2 2021 | $98,000 | +4800.0% | 4,656 | +3595.2% | 0.00% | – |
| Q1 2021 | $2,000 | -99.6% | 126 | -99.5% | 0.00% | – |
| Q4 2020 | $510,000 | – | 24,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |